ADVFN US – Market Content Editor
-

Oil could climb to $200 if the conflict lasts through June, strategist warns
Brent crude prices could spike to as high as $200 per barrel — potentially pushing U.S. gasoline prices to roughly $7 per gallon — if the war involving Iran continues through the end of June and the Strait of Hormuz remains mostly closed to shipping, according to analysts at Macquarie. Similar concerns were voiced by…
-

Bernstein Says Crypto Stocks May Be Approaching a Bottom Despite Weak Q1 Outlook
Shares of companies tied to the cryptocurrency sector could be nearing a cyclical low, according to analysts at Bernstein, who said the recent downturn has created attractive entry points for investors. In a research note this week, the firm said geopolitical tensions combined with “temporary crypto weak sentiment is offering big discounts (~60% below 2025…
-

Stocks Recover From Sharp Sell-Off but Dow Still Closes Lower Amid Iran Uncertainty
U.S. stocks staged a dramatic intraday reversal on Thursday but ultimately finished the shortened holiday week on a mixed note, as investors wrestled with conflicting signals about the trajectory of the conflict in Iran. President Trump’s televised address the prior evening — in which he said the war could last another two to three weeks…
-

Goldman Sachs keeps $5,400 gold forecast despite recent pullback
Goldman Sachs continues to project that gold could reach $5,400 per troy ounce by the end of 2026, citing expected Federal Reserve interest-rate cuts, a normalization in speculative positioning, and ongoing central bank demand for bullion. The bank’s analysts Lina Thomas and Daan Struyven are maintaining that target even though gold has fallen roughly 15%…
-

Wall Street futures fall as Middle East tensions escalate and oil surges over 11%: Dow Jones, S&P and Nasdaq futures
Dow Jones, S&P 500 and Nasdaq futures are currently pointing to a sharply lower open on Thursday, with stocks likely to give back ground after moving substantially higher over the two previous sessions. Renewed concerns about an escalation of the conflict in the Middle East are likely to weigh on Wall Street following President Donald…
-

US labor market shows resilience as jobless claims decline and trade deficit reaches $57.3 billion in February
First time claims for U.S. unemployment benefits unexpectedly edged lower in the week ended March 28th, according to a report released by the Labor Department on Thursday. The report said initial jobless claims dipped to 202,000, a decrease of 9,000 from the previous week’s revised level of 211,000. Economists had expected jobless claims to inch…
-

Ceasefire Hopes and Strong Economic Data Power Wall Street Rally to Start Q2
U.S. stocks kicked off the second quarter with a broad-based rally on Wednesday as growing optimism around a potential de-escalation in the Iran conflict combined with better-than-expected economic data to lift all three major indexes. The tech-heavy Nasdaq led the charge, climbing more than one percent, while defensive energy names lagged as crude oil prices…
-

DeFi Technologies appoints Jacob Lindberg as Valour CRO to drive European expansion
DeFi Technologies Inc. (NASDAQ:DEFT) said its subsidiary Valour Inc. has appointed Jacob Lindberg as Chief Revenue Officer, as the digital asset manager pushes to expand its presence across the Nordic region and broader European markets. Lindberg will lead Valour’s commercial strategy and revenue growth, focusing on expanding distribution of the company’s digital asset exchange-traded products…
-

Intel to repurchase Apollo’s stake in Irish chip facility for $14.2 billion
Intel (NASDAQ:INTC) announced it will spend $14.2 billion to repurchase the 49% stake it previously sold to Apollo Global Management in its semiconductor manufacturing facility in Ireland, restoring full ownership of the plant as its financial position improves and demand for chips rises with the growth of artificial intelligence. Shares of Intel climbed about 6%…
-

Cyclerion to combine with Korsana Biosciences in $380 million merger deal
Cyclerion Therapeutics (NASDAQ:CYCN) announced it has signed a definitive merger agreement with privately held Korsana Biosciences in an all-stock transaction, according to a company press release. The announcement comes as Cyclerion shares trade around $1.55, giving the company a market capitalization of roughly $5.9 million, with the stock down 4.3% over the past week. Following…